Brief: SciSparc submitted IND Application To The FDA For SCI-110 Phase IIb Clinical Trial For Patients With Tourette Syndrome
23/08/2024 23:02
Aug 23 (Reuters) - Scisparc Ltd SPRC.O :
* SCISPARC SUBMITTED IND APPLICATION TO THE FDA FOR SCI-110
PHASE
IIB CLINICAL TRIAL FOR PATIENTS WITH TOURETTE SYNDROME
Source text for Eikon: ID:nGNX6R272Q
Further company coverage: SPRC.O
((reuters.briefs@thomsonreuters.com;))